| 0 (0%) | 09-27 09:29 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 50.17 | 1-year : | 58.6 |
| Resists | First : | 42.95 | Second : | 50.17 |
| Pivot price | 42.36 |
|||
| Supports | First : | 41.97 |
Second : | 41.37 |
| MAs | MA(5) : | 42.51  |
MA(20) : | 42.23 |
| MA(100) : | 40.36 |
MA(250) : | 38.94 |
|
| MACD | MACD : | 0.3 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 60 |
D(3) : | 68.3 |
| RSI | RSI(14): 60.8 |
|||
| 52-week | High : | 42.95 | Low : | 32.83 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ PVAL ] has closed below upper band by 36.2%. Bollinger Bands are 37.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 42.64 - 42.88 | 42.88 - 43.1 |
| Low: | 41.67 - 41.99 | 41.99 - 42.28 |
| Close: | 42.05 - 42.51 | 42.51 - 42.93 |
Sat, 23 Aug 2025
Tailoring of the physicochemical and biological properties of polypyrrole colloids with the help of stabilizers - ScienceDirect.com
Fri, 22 Aug 2025
PVAL: A Thumbs Up For This Actively Managed ETF - Seeking Alpha
Mon, 09 Jun 2025
PVAL: Value Means Overvalued In Today's Markets (NYSEARCA:PVAL) - Seeking Alpha
Sun, 30 Mar 2025
FDM 3D-printed oral dosage form of prednisolone – Improvement of printability and influencing drug release - ScienceDirect.com
Fri, 21 Feb 2025
PVAL: A Low Valuation Fund Outperforming Peers - Seeking Alpha
Tue, 21 Jan 2025
Genetic variation reveals the therapeutic potential of BRSK2 in idiopathic pulmonary fibrosis - BMC Medicine
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|